z-logo
open-access-imgOpen Access
Evidence Supporting the Use of Recombinant Activated Factor VII in Congenital Bleeding Disorders
Author(s) -
Pär I. Johansson,
Sisse Rye Ostrowski
Publication year - 2011
Publication title -
european oncology and haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.116
H-Index - 6
eISSN - 2045-5283
pISSN - 2045-5275
DOI - 10.17925/eoh.2011.07.01.71
Subject(s) - medicine , adverse effect , haemophilia , thrombelastography , factor viia , randomized controlled trial , recombinant factor viia , clinical trial , thrombin generation , thrombin , surgery , anesthesia , coagulation , tissue factor , platelet

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom